start portlet menu bar

Προβολή διαδικτυακού περιεχομένου

Display portlet menu
end portlet menu bar

Clinical protection study of pseudorabies vaccine (AUSKIPRA® GN bartha k61 strain) in piglets infected with new Chinese PRV variant

Αρχική Γνώση Clinical protection study of pseudorabies vaccine (AUSKIPRA® GN bartha k61 strain) in piglets infected with new Chinese PRV variant

Clinical protection study of pseudorabies vaccine (AUSKIPRA® GN bartha k61 strain) in piglets infected with new Chinese PRV variant

Since 2011, several pseudorabies (PR) outbreaks have damaged Chinese swine industry. The purpose of this experiment is to test the efficacy of pseudorabies vaccine AUSKIPRA® GN (HIPRA) against new pseudorabies virus variant (AH02).

Σχετικά με αυτό το άρθρο

Δημοσιευτηκε σε

APVS Congress, 2015

Συντάκτες

Zeng, R.; Wang, J.; Torrents, D.; Martinez, C.; Pedrazuela, R.; Galé, I.

Περίληψη

In this study AUSKIPRA® GN reconstituted with RED solvent reduce mortality, lung lesions and fever. Therefore, AUSKIPRA® GN can provide clinical protection in front of new PRV strains.

Σχετικές υπηρεσίες

Σχετικά προϊόντα

Μοιραστείτε